If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Update re. Suspension

31 Jul 2020 12:14

RNS Number : 7940U
Asimilar Group PLC
31 July 2020
Β 

Β 

Β 

31 July 2020

Β 

Β 

Asimilar Group plc

Β 

('Asimilar' or the 'Company')

Β 

Update re. Suspension

Β 

Following the announcement on 14 February 2020 regarding the possible investment in Sentiance NV, the Company's shares were suspended from trading on AIM with immediate effect, as the transaction would be classified as a reverse takeover in accordance with Rule 14 of the AIM Rules for Companies ("AIM Rules"). Ordinarily under the AIM Rules, the Company has six months from the date of suspension to publish an admission document setting out, inter alia, details of the proposed transaction or confirm these discussions have ceased. If neither of these outcomes is achieved, trading in the Company's shares on AIM will be cancelled.

Β 

Due to market impact of Covid-19, the Company has been granted an extension from six to twelve months from 14 February 2020 for publishing such an admission document or to confirm discussions concerning the proposed investment have ceased.

Β 

Asimilar is continuing to work with its Nominated Adviser and other professional advisers on its admission document in relation to the proposals announced on 4 and 12 March 2020, although there is no guarantee that a formal agreement will be reached.

Β 

Further announcements will be made in due course.

Β 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Β 

-Ends-

Contacts

Asimilar Group plc

Β 

John Taylor, Non-Executive Chairman

via Buchanan

Β 

Β 

Cairn Financial Advisers LLP

Β 

Sandy Jamieson / Liam Murray

Tel: +44 20 7213 0880

Β 

Β 

Peterhouse Capital Limited

Β 

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

Β 

Β 

Buchanan Communications Limited

Β 

Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
UPDRBMBTMTBJBMM
Date   Source Headline
18th Nov 20057:01 amRNSPositive Product Test Results
20th Oct 20057:00 amRNSTrading Statement
1st Aug 20059:27 amRNSBoard Appointment
29th Jul 20057:01 amRNSEgypt contract gain
8th Jul 200512:14 pmRNSResult of EGM
29th Jun 20055:30 pmRNSInterim Results
21st Jun 20057:00 amRNSOverseas Contract Gains
15th Jun 20054:03 pmRNSNotice of EGM
15th Jun 20052:21 pmRNSBoard Appointment
10th Jun 20057:00 amRNSOverseas Contract Gains
2nd Jun 20057:01 amRNSUS Collaboration deal
25th May 200512:30 pmRNSIssue of Equity
29th Mar 20051:13 pmRNSAGM Statement
2nd Feb 20054:51 pmRNSFinal Results Replacement
14th Jan 20051:39 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.